$BIIB 0.52 Developing

Notable posts

• @ripster47 bullish 42 eng

  $BIIB 🚨 Super strong FDA Approves First At-home Starting Dose for Alzheimer’s Disease Treatment

  view on X →
• @tenet_research neutral 25 eng

  Tenet Market Wake-Up Summary 📷📷 June.08.26 $SPX $AAPL $NVDA $AMZN $BA $MA $V $UAL $AAL $DAL $JBLU $NOK $ABAT $UBER $NBIS $SPOT $CRWV $PFE $FCEL $CPB $ALOT $BIIB $CROX $CTSH $WRB $CBRS $ALL $CSR $GMHS $TNGX $MRVL $BW @ripster47 | @TENETTRADEGROUP | @TenetCharts https://t.co/zKMUGXnV7I

  view on X →
• @faststocknewss neutral 4 eng

  BIOGEN $BIIB DISCLOSES R&D, MILESTONE CHARGES IMPACTING Q2, Q3 ADJ EPS Biogen expects charges from acquired in-process R&D, upfront and milestone payments, tied to business development deals, to affect adjusted diluted EPS, per an SEC filing: - Q2 2026: ~$164M in charges, a $0.95 adjusted diluted EPS impact - Q3 2026: $290M-$320M in charges, a $1.75-$1.95 adjusted diluted EPS impact LSEG/IBES consensus is $3.20 for Q2 and $3.98 for Q3.

  view on X →